Conversion from the “oncogene addiction” to “drug addiction” by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation

Lung Cancer ◽

10.1016/j.lungcan.2011.11.007 ◽

2012 ◽

Vol 76 (3) ◽

pp. 292-299 ◽

Author(s):

Kenichi Suda ◽

Kenji Tomizawa ◽

Hirotaka Osada ◽

Yoshihiko Maehara ◽

Yasushi Yatabe ◽

...

Keyword(s):

Lung Cancer ◽

Drug Addiction ◽

Egfr Mutation ◽

Oncogene Addiction ◽

Activating Egfr Mutation

Download Full-text

P76.32 Real-World Data in Non-Small Cell Lung Cancer with Activating EGFR Mutation Treated with First and Second Generation TKI

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1089 ◽

2021 ◽

Vol 16 (3) ◽

pp. S600

Author(s):

D. Juarez ◽

R. Ruiz ◽

J.M. Gutierrez ◽

L. Mas ◽

Z. Morante ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Real World Data ◽

Activating Egfr Mutation ◽

First And Second Generation

Download Full-text

Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non–Small-Cell Lung Cancer with Activating EGFR Mutation

Journal of Thoracic Oncology ◽

10.1097/jto.0000000000000569 ◽

2015 ◽

Vol 10 (8) ◽

pp. 1189-1194 ◽

Author(s):

Bhumsuk Keam ◽

Soo Jin Lee ◽

Tae Min Kim ◽

Jin Chul Paeng ◽

Se-Hoon Lee ◽

...

Keyword(s):

Lung Cancer ◽

Positron Emission Tomography ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Total Lesion Glycolysis ◽

Emission Tomography ◽

Small Cell Lung ◽

Positron Emission ◽

Activating Egfr Mutation

Download Full-text

First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice?

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3516-1 ◽

2018 ◽

Vol 81 (3) ◽

pp. 443-453 ◽

Author(s):

Shuyun Wang ◽

Aiqin Gao ◽

Jie Liu ◽

Yuping Sun

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Activating Egfr Mutation ◽

Download Full-text

First-line therapy of advanced non-small cell lung cancer not harboring an activating EGFR mutation

Lung Cancer Therapy Annual 7 ◽

10.3109/9781841848679.006 ◽

2012 ◽

pp. 59-74

Author(s):

Cesare Gridelli ◽

Antonio Rossi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Activating Egfr Mutation

Download Full-text

P1.01-77 Osimertinib in the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutation from Circulating Tumor DNA

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.633 ◽

2018 ◽

Vol 13 (10) ◽

pp. S492

Author(s):

C. Park ◽

H. Cho ◽

Y.D. Choi ◽

I. Oh ◽

Y. Kim

Keyword(s):

Lung Cancer ◽

Egfr Mutation ◽

Circulating Tumor Dna ◽

Line Treatment ◽

Small Cell Lung ◽

Activating Egfr Mutation ◽

Tumor Dna ◽

First Line Treatment

Download Full-text

P2.16-19 Real World Data in Non-Small Cell Lung Cancer with Activating EGFR Mutation - A Multicenter Observational Study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1886 ◽

2019 ◽

Vol 14 (10) ◽

pp. S872-S873 ◽

Author(s):

M. Kimura ◽

K. Nishino ◽

Y. Yano ◽

M. Mori ◽

H. Suzuki ◽

...

Keyword(s):

Lung Cancer ◽

Observational Study ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell Lung ◽

Real World Data ◽

Multicenter Observational Study ◽

Activating Egfr Mutation

Download Full-text

A network meta-analysis of nonsmall-cell lung cancer patients with an activating EGFR mutation

Medicine ◽

10.1097/md.0000000000011569 ◽

2018 ◽

Vol 97 (30) ◽

pp. e11569 ◽

Author(s):

Jia-Zhou Lin ◽

Song-Kun Ma ◽

Sheng-Xi Wu ◽

Shu-Han Yu ◽

Xu-Yuan Li

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Meta Analysis ◽

Nonsmall Cell Lung Cancer ◽

Lung Cancer Patients ◽

Activating Egfr Mutation

Download Full-text

P1.02-051 Concomitant Driver Mutations in Advanced Stage Non-Small-Cell Lung Cancer of Adenocarcinoma Subtype with Activating EGFR-Mutation

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.635 ◽

2017 ◽

Vol 12 (1) ◽

pp. S518-S519

Author(s):

Jens Benn Sørensen ◽

Morten Grauslund ◽

Linea Melchior ◽

Jan Jakobsen ◽

Eric Santoni-Rugiu

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Driver Mutations ◽

Advanced Stage ◽

Small Cell Lung ◽

Activating Egfr Mutation

Download Full-text

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)

PLoS ONE ◽

10.1371/journal.pone.0147599 ◽

2016 ◽

Vol 11 (3) ◽

pp. e0147599 ◽

Author(s):

Jacques De Grève ◽

Jan Van Meerbeeck ◽

Johan F. Vansteenkiste ◽

Lore Decoster ◽

Anne-Pascale Meert ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Study ◽

Prospective Evaluation ◽

Small Cell Lung ◽

Activating Egfr Mutation ◽

Caucasian Patients

Download Full-text

A Combined test using both cell sediment and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients

Cytopathology ◽

10.1111/cyt.12517 ◽

2018 ◽

Vol 29 (2) ◽

pp. 150-155 ◽

Author(s):

A. Kawahara ◽

C. Fukumitsu ◽

K. Azuma ◽

T. Taira ◽

H. Abe ◽

...

Keyword(s):

Lung Cancer ◽

Pleural Effusion ◽

Cancer Patients ◽

Egfr Mutation ◽

Cell Free Dna ◽

Lung Cancer Patients ◽

Free Dna ◽

Combined Test ◽

Increased Sensitivity ◽

Activating Egfr Mutation

Download Full-text